What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study
Journal of Cystic Fibrosis · 2025-01 · 24 (1) · 187-192
DOI: 10.1016/j.jcf.2024.11.003 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Journal of Cystic Fibrosis, 2025-01. Verfasst von Robin S Everhart und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: reverhart@vcu.edu. Hauptthemen laut MEDLINE: Cystic Fibrosis, Aminophenols, Benzodioxoles, Indoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: reverhart@vcu.edu.
- Division of Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.
- Community Member, former STRC Steering Committee Member, c/o Cystic Fibrosis Foundation, Bethesda, MD, USA.
- Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
- Department of Pediatrics, Division of Pediatric Psychology, Mott Children's Hospital, University of Michigan Health, Ann Arbor, MI, USA.
- Division of Pulmonary and Critical Care, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Everhart, R. S., McWilliams, E., Maggs, J., Sawicki, G. S., Sconiers, T., Smith, K., Yablon, D., Butcher, J., Prickett, M., Bacon, C., Goodman, A., Gifford, A. H., Mayer-Hamblett, N., Nichols, D. P., & Riekert, K. A. (2025). What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2024.11.003
Vancouver
Everhart RS, McWilliams E, Maggs J, Sawicki GS, Sconiers T, Smith K, et al. What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2024.11.003
BibTeX
@article{Everhart2025,
author = {Everhart, Robin S and McWilliams, Emma and Maggs, Jill and Sawicki, Gregory S and Sconiers, Takeera and Smith, Kyle and Yablon, Dana and Butcher, Jennifer and Prickett, Michelle and Bacon, Callie and Goodman, Andrea and Gifford, Alex H and Mayer-Hamblett, Nicole and Nichols, David P and Riekert, Kristin A},
title = {What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2024.11.003}
}
EUVIMED